YUMAB
Antibodies, antibody fragments and antigens in the nature of pharmaceuticals for the treatment of cancer, haematopoietic diseases, autoimmune diseases, neurodegenerative diseases, metabolic diseases, eye diseases, infections, diseases of heart and circulation, bone diseases, transplantation, sepsis, intoxications, and adverse drug reactions
Registered · April 25, 2016 · 79191669 ·